1-8 of 8
Avery D. Posey
Close
Sort by
Journal Articles

Fratricide-Resistant Anti-CD2 Chimeric Antigen Receptor T-Cells with Endogenous CD2 Knockout Are Highly Effective Against T-Cell Neoplasms

Mathew G. Angelos, Ruchi P. Patel, Yi-Hao Chiang, Wei Xie, Raymone Pajarillo, Carolyn E. Shaw, Ekta Singh, Jason Xu, Avery D. Posey, Alain Rook, Antonia Rotolo, Vinodh Pillai, Stefano A. Pileri, David T. Teachey, Marco Ruella
Journal: Blood
Blood (2023) 142 (Supplement 1): 885.
https://doi.org/10.1182/blood-2023-181282
Published: 2023
Journal Articles

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Inkook Chun, MS, Ki Hyun Kim, PhD, Yi-Hao Chiang, MD, Wei Xie, MD, Yong Gu Gu Lee, PhD, Raymone Pajarillo, MS, Antonia Rotolo, MD PhD, Olga Shestova, PhD, Seok Jae Hong, MS, Mohamed Abdel-Mohsen, PhD, Maria Wysocka, PhD, Hatcher J. Ballard, BS, David M. Barrett, Avery D. Posey, PhD, Daniel Powell, Jr., PhD, Saar I. Gill, MDPhD, Stephen J. Schuster, MD, Stefan K. Barta, MDMRCP,MS, Alain H Rook, MD, Carl H June, MD, Marco Ruella, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-136860
Published: 2020
Journal Articles

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells

Brief Report
Marco Ruella, David M. Barrett, Olga Shestova, Jessica Perazzelli, Avery D. Posey, Jr, Seok Jae Hong, Miroslaw Kozlowski, Simon F. Lacey, J. Joseph Melenhorst, Carl H. June, Saar I. Gill
Journal: Blood
Blood (2020) 135 (7): 505–509.
https://doi.org/10.1182/blood.2019001859
Published: 2020
Includes: Supplemental data
Journal Articles

A Cellular Antidote to Specifically Deplete Anti-CD19 Chimeric Antigen Receptor (CAR19) Positive Cells

Marco Ruella, MD, David M. Barrett, Olga Shestova, PhD, Jessica Perazzelli, PhD, Avery D. Posey, PhD, Miroslaw Kozlowski, PhD, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Carl H June, MD, Saar I. Gill, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4463.
https://doi.org/10.1182/blood.V130.Suppl_1.4463.4463
Published: 2017
Journal Articles

Glycopeptide-Specific Chimeric Antigen Receptor Targeting of T Cell Leukemia

Avery D. Posey, PhD, Robert D. Schwab, Alina Boestaneau, PhD, Laura A. Johnson, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 4803.
https://doi.org/10.1182/blood.V124.21.4803.4803
Published: 2014
Journal Articles

Signaling Domain of Chimeric Antigen Receptors Can Reprogram T Cells

Omkar Uday Kawalekar, MS, BS, Roddy O'Connor, PhD, Sonia Guedan, PhD, Joseph Fraietta, PhD, Avery D. Posey, PhD, John Scholler, Michael C Milone, MD PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 551.
https://doi.org/10.1182/blood.V124.21.551.551
Published: 2014
Journal Articles

ICOS-based chimeric antigen receptors program bipolar T H 17/T H 1 cells

Sonia Guedan, Xi Chen, Aviv Madar, Carmine Carpenito, Shannon E. McGettigan, Matthew J. Frigault, Jihyun Lee, Avery D. Posey, Jr, John Scholler, Nathalie Scholler, Richard Bonneau, Carl H. June
Journal: Blood
Blood (2014) 124 (7): 1070–1080.
https://doi.org/10.1182/blood-2013-10-535245
Published: 2014
Includes: Supplemental data
Journal Articles

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Omkar Uday Kawalekar, MS, BS, Avery D. Posey, Jr., Joseph Fraietta, Jihyun Lee, John Scholler, Yangbing Zhao, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 2902.
https://doi.org/10.1182/blood.V122.21.2902.2902
Published: 2013